A comprehensive view of Immune System Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bloomberg reports Novartis to sell some ophthalmology products that treat the front of the eye; as part of new strategy, Novartis to focus on cardiovascular diseases, neuroscience, immunology, hematology, solid tumors

Multiple new autoimmune biosimilars to hit US market in 2023, offer opportunity to reduce drug costs; autoimmune conditions affect 1% of insurance plan members but accounted for 42% of insurance plan specialty spend in 2022: CVS Health

German drug maker Evotec partners with Janssen Biotech to develop first-in-class targeted immune-based cancer therapies; Evotec, Janssen to work together during pre-clinical R&D, Janssen to handle clinical development, commercialization

Sun Pharmaceuticals acquires Concert Pharmaceuticals for US$576.0M; deal includes Concert’s experimental deuruxolitinib to treat alopecia areata, an autoimmune disorder in which the immune system attacks hair follicles

AbbVie partners with Anima Biotech to develop mRNA drugs focused on three targets in oncology, immunology; AbbVie to have exclusive rights to license, develop, commercialize the drugs in deal worth up to US$540.0M

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count